KKR

Infinx Healthcare Launches New R&D Center in Bengaluru July 15, 2024 Spanning 12,000 sq ft, this R&D center will focus on AI-driven product development, engineering, innovation, data science, and machine learning.

KKR to Acquire Kerala's Baby Memorial Hospitals for $300 Mn July 2, 2024 KKR & Co has planned to acquire a 70% controlling stake in Kerala's Baby Memorial Hospitals (BMH) for $300 million (INR 2500 Cr).

After Mankind Pharma, Now Blackstone, KKR & Carlyle in Talks to Acquire Bharat Serums & Vaccines May 23, 2024 Advent International, the current owner of BSV, aims to sell its entire stake. Non-binding bids are expected by the end of this month.

After Acquiring Healthium Medtech, KKR in Talks to Acquire 26% Stake in Healthcare BPO Infinx May 21, 2024 The strategic move aims to expand Infinx's capabilities by acquiring smaller companies in the same field, known as bolt-on acquisitions, thereby enhancing its service offerings.

KKR Acquires Healthium Medtech for INR 7000 Cr May 6, 2024 In a significant development within the healthcare industry, KKR, a global investment firm, has acquired Healthium Medtech (formerly Sutures India) from Apax Partners, its current private equity owners.

KKR & Co in Talks to Acquire Healthium Medtech for $1 Bn April 29, 2024 According to people familiar with the matter, deliberations are ongoing, and talks could still fall apart or another buyer could emerge.

KKR, Carlyle, EQT, Others in Race to Acquire Healthium March 11, 2024 The bidding war, expected to value the company at $750-850 million, marks a significant acquisition opportunity in the medical devices sector.

Major Acquisition on the Cards for HCG as EQT, TPG, & KKR Betting for Majority Stake February 19, 2024 Global buyout funds, including EQT, TPG Capital, and KKR, express interest in acquiring a controlling stake currently held by CVC Capital.

Aster's India Unit Draws Bidders' Attention, Valuing Biz at $1.5 Bn October 12, 2023 Global healthcare company, Aster DM Healthcare has garnered the attention of potential investors for its India unit, with an approximate valuation of $1.9 billion.